Home / Health / Female Viagra: Hype or Hope for Libido?
Female Viagra: Hype or Hope for Libido?
23 Nov
Summary
- Addyi, 'female Viagra,' targets brain receptors, not physical arousal.
- Australian TGA hasn't approved Addyi due to doubtful effectiveness.
- Low libido is common, influenced by many factors beyond one pill.
Conversations around low female libido are increasing, with some women turning to Addyi, known as 'female Viagra.' This medication targets brain receptors influencing desire, unlike male Viagra which aids physical arousal. However, Australian health authorities have not approved Addyi due to concerns about its effectiveness and safety profile. Studies indicate only a marginal improvement in sexual experiences for daily users, with significant potential side effects and drug interactions.
Low libido is a widespread concern, particularly during perimenopause and menopause, due to hormonal changes and other life stressors. Factors like fatigue, relationship issues, and psychological well-being play crucial roles. While Addyi operates on a different mechanism than traditional Viagra, its modest benefits are weighed against considerable risks, including dizziness, drowsiness, and dangerous interactions with alcohol and other medications.
Doctors assess low libido by considering stress, sleep, relationships, and hormonal status. Effective management often involves lifestyle changes, hormone therapy, or counseling. The article emphasizes that a single pill is unlikely to be the sole answer, advocating for comprehensive, individualized care and open communication with healthcare providers. Women are cautioned against obtaining unapproved medications online due to safety risks.
